ConductScience.org, home

Paper24709221

Direct comparison of two albumin-based paclitaxel-loaded nanoparticle formulations: is the crosslinked version more advantageous?

Li C and 8 others. Int J Pharm, 2014. Cited by 60 papers, by iCite.

Cite this record

ConductScience Library. Direct comparison of two albumin-based paclitaxel-loaded nanoparticle formulations: is the crosslinked version more advantageous? Papers, record 24709221. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24709221

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Direct comparison of two albumin-based paclitaxel-loaded nanoparticle formulations: is the crosslinked version more advantageous?
PubMed
Journal
Int J Pharm
PubMed
Year
2014
PubMed
Publication types
Comparative Study, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
60
iCite
Relative citation ratio, by iCite
2.04
iCite
Revised in PubMed
2015-11-19
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Li CChunlei
2Li YYanhui
3Gao YYuqing
4Wei NNa
5Zhao XXi
6Wang CCaixia
7Li YYongfeng
8Xiu XXian
9Cui JJingxia

Source PubMed

Download CSV of authors

Topics21

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic Agents, PhytogenicMajor topic
Cross-Linking ReagentsMajor topic
Drug CarriersMajor topic
PaclitaxelMajor topic
Prostatic NeoplasmsMajor topic
Albumin-Bound Paclitaxel
Albumins
Animals
Cell Line, Tumor
Chemistry, Pharmaceutical
Drug Stability
Injections, Intravenous
Male
Mice
Nanoparticles
Nanotechnology
Permeability
Rats, Wistar
Solubility
Technology, Pharmaceutical
Tissue Distribution

Source PubMed

Download CSV of topics

Cited by27

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 60 citations.

PMIDTitleJournalYearIn PapersSource
42198250Human Serum Albumin as a Prodrug Carrier for Tumor Therapy: Mechanisms, Applications, and Future Perspectives.Pharmaceutics2026https://conductscience.org/library/papers/42198250PubMed
40870994Enhancing Parenteral Nutrition via Supplementation with Antioxidant Lutein in Human Serum Albumin-Based Nanosuspension.Pharmaceutics2025https://conductscience.org/library/papers/40870994PubMed
40725126Strategic Advances in Targeted Delivery Carriers for Therapeutic Cancer Vaccines.Int J Mol Sci2025https://conductscience.org/library/papers/40725126PubMed
40162333Targeting Delivery of Dexamethasone to Inflamed Joints by Albumin-Binding Peptide Modified Liposomes for Rheumatoid Arthritis Therapy.Int J Nanomedicine2025https://conductscience.org/library/papers/40162333PubMed
39950848Periodate-Mediated Cross-Linking for the Preparation of Catechol Conjugated Albumin Nanoparticles Used for in Vitro Drug Delivery.ACS Appl Bio Mater2025https://conductscience.org/library/papers/39950848PubMed
39766308Core-Shell PLGA Nanoparticles: In Vitro Evaluation of System Integrity.Biomolecules2024https://conductscience.org/library/papers/39766308PubMed
39758671A Nanotheranostic Agent for Synergistic Antitumor Chemo/Phototherapy Prepared by Paclitaxel-Induced Self-Assembly of PEGylated Human Serum Albumin with Prolonged Circulation.ACS Omega2024https://conductscience.org/library/papers/39758671PubMed
39638910A Novel Self-Assembled Paclitaxel Nanodispersion Facilitates Rapid In-Vitro/In-Vivo Dissociation and Protein Binding.AAPS PharmSciTech2024https://conductscience.org/library/papers/39638910PubMed
38918979Folate-Modified Curcumin-Loaded Nanoparticles for Overcoming Delivery Challenges in Cancer Treatment: A Narrative Review.Curr Pharm Biotechnol2025https://conductscience.org/library/papers/38918979PubMed
38323081GP60 and SPARC as albumin receptors: key targeted sites for the delivery of antitumor drugs.Front Pharmacol2024https://conductscience.org/library/papers/38323081PubMed
37204680Medium-chain triglyceride-stabilized docetaxel-loaded HSA nanoparticles effectively inhibited metastatic non-small cell lung cancer.Drug Deliv Transl Res2023https://conductscience.org/library/papers/37204680PubMed
36839841Intravital Microscopy Reveals Endothelial Transcytosis Contributing to Significant Tumor Accumulation of Albumin Nanoparticles.Pharmaceutics2023https://conductscience.org/library/papers/36839841PubMed
35456562Emerging Albumin-Binding Anticancer Drugs for Tumor-Targeted Drug Delivery: Current Understandings and Clinical Translation.Pharmaceutics2022https://conductscience.org/library/papers/35456562PubMed
35059018Polymer-based nanoparticles: fabrication to applications-the many faces of DC8,9PC and albumin.Biophys Rev2021https://conductscience.org/library/papers/35059018PubMed
34202848Paclitaxel-Loaded Folate-Targeted Albumin-Alginate Nanoparticles Crosslinked with Ethylenediamine. Synthesis and In Vitro Characterization.Polymers (Basel)2021https://conductscience.org/library/papers/34202848PubMed
33396604Synthesis and In Vitro Assessment of pH-Sensitive Human Serum Albumin Conjugates of Pirarubicin.Pharmaceuticals (Basel)2020https://conductscience.org/library/papers/33396604PubMed
31195727Albumin Nanovectors in Cancer Therapy and Imaging.Biomolecules2019https://conductscience.org/library/papers/31195727PubMed
29946256Human Albumin Fragments Nanoparticles as PTX Carrier for Improved Anti-cancer Efficacy.Front Pharmacol2018https://conductscience.org/library/papers/29946256PubMed
29872625Substance P-modified human serum albumin nanoparticles loaded with paclitaxel for targeted therapy of glioma.Acta Pharm Sin B2018https://conductscience.org/library/papers/29872625PubMed
28599410Resistance to nanoparticle albumin-bound paclitaxel is mediated by ABCB1 in urothelial cancer cells.Oncol Lett2017https://conductscience.org/library/papers/28599410PubMed

See all 27 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ALB213PubTator's text mininghttps://conductscience.org/library/genes/213NCBI Gene
SPARC6678PubTator's text mininghttps://conductscience.org/library/genes/6678NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/24709221

GET https://conductscience.org/api/papers/v1/24709221/cited_by?page=2